Evidence map›Paper›PMID 39188844›Full record

ReviewMaedica2024

Laser Lithotripsy in Renal Lithiasis - 2023 Update - a Narative Review.

Bogdan Buzescu, Cosmin Cozma, Petrisor Geavlete, Razvan Multescu, Dragos Georgescu, Cosmin Ene, Catalin Bulai, Bogdan Geavlete

Abstract readReview
In one paragraph

Review in Maedica, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Bogdan Buzescu"Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania.
Cosmin Cozma"Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania.
Petrisor Geavlete"Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania.
Razvan Multescu"Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania.
Dragos Georgescu"Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania.
Cosmin Ene"Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania.
Catalin Bulai"Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania.
Bogdan Geavlete"Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionUrolithiasis is a serious health issue that is constantly getting worse around the world. In relation to laser lithotripsy, new techniques and technological advancements have emerged, giving urologists a wide range of choices for treating stone disease. The objective of the present review is to provide an overview of the most current developments and show how effective they are for reducing complications and boosting surgical effectiveness. MATERIAL AND

methodIn October 2023, we performed a comprehensive search of the literature, including relevant articles using the PubMed international database to identify related publications concerning ureteroscopic laser stone lithotripsy in renal lithiasis. Both review and original articles were selected. Searches were limited to studies written in English which involved human and adult subjects.

resultsAll eligible studies concerning ureteroscopic laser lithotripsy were published in 2022 and 2023. They were conducted in Asia (5/10), the North America (3/10) and Europe (2/10), and totalized 1570 patients with an age range between 18 and 85 years. Regarding the primary efficacy outcome, all studies focused on stone free rates (SFRs), complications and average operative time.

conclusionThe rising frequency and incidence of stone disease has led to ongoing breakthroughs in endourology through technological advancements and ongoing developments. Unlike the relatively well-known Holmium laser, which has several uses in the field of stone lithotripsy, Thulium fiber laser (TFL) is a brand-new technological arrangement.

Identifiers

PMID39188844
PMCPMC11345066

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.